Calcitriol May Have Role in HRPC Salvage Therapy
High-dose calcitriol and docetaxel, each given separately one day a week for six weeks, appear to be an effective and well-tolerated combination for men living with metastatic hormone-refractory prostate cancer (HRPC) previously treated with docetaxel-based chemotherapy, Italian investigators conclude.
The e-mail address(es) that you supply to use this service will only be used to send the requested article.